Home Biosimilar Antibodies Others Others antibody Azintuxizumab (Anti-SLAMF7 / CS1) For research use only.
Not for use in humans.

Azintuxizumab (Anti-SLAMF7 / CS1)

Synonyms: ABBV-383

Azintuxizumab (Anti-SLAMF7 / CS1) is a monoclonal IgG4 bispecific antibody targeting B-cell maturation antigen (BCMA). It has the potential for the research of relapsed/refractory multiple myeloma (RRMM). MW :140.12 KD.

Azintuxizumab (Anti-SLAMF7 / CS1)

Purity & Quality Control

Batch: A306101 Purity: 99% Protein concentration: 9.517mg/ml Endotoxin Level: ＜1EU/mg
99

Biological Activity

Description Azintuxizumab (Anti-SLAMF7 / CS1) is a monoclonal IgG4 bispecific antibody targeting B-cell maturation antigen (BCMA). It has the potential for the research of relapsed/refractory multiple myeloma (RRMM). MW :140.12 KD.

Product Details

CAS No. 1826819-57-1
Isotype Human IgG1
Source CHO
Formulation 100mMPro-Ac,20mMArg-Ac，pH5.0
Storage
(From the date of receipt)		 Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.

Comparison of Clones for

*Literature analysis of various clone (for this target) products available on the market shows that Selleck's selected clones are more frequently applied. (data until September 2024)

Tech Support

If you have any other enquiries, please leave a message.

* Indicates a Required Field

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.
Tags: buy Azintuxizumab (Anti-SLAMF7 / CS1) | Azintuxizumab (Anti-SLAMF7 / CS1) supplier | purchase Azintuxizumab (Anti-SLAMF7 / CS1) | Azintuxizumab (Anti-SLAMF7 / CS1) cost | Azintuxizumab (Anti-SLAMF7 / CS1) manufacturer | order Azintuxizumab (Anti-SLAMF7 / CS1) | Azintuxizumab (Anti-SLAMF7 / CS1) distributor